{
    "clinical_study": {
        "@rank": "48465", 
        "arm_group": [
            {
                "arm_group_label": "LVX-AMX", 
                "arm_group_type": "Active Comparator", 
                "description": "subject is treated with LAV-AMX, then followed by placebo."
            }, 
            {
                "arm_group_label": "TCM treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "subject is treated with TCM"
            }
        ], 
        "brief_summary": {
            "textblock": "Traditional Chinese Medicine (TCM) could be used to treat Recurrent urinary tract infection\n      (RUTI)."
        }, 
        "brief_title": "Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Recurrent Urinary Tract Infection", 
        "condition_browse": {
            "mesh_term": "Urinary Tract Infections"
        }, 
        "detailed_description": {
            "textblock": "Antibiotics and TCM are used to treat RUTI to evaluate treatment efficiencies."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  uncomplicated RUTI\n\n        Exclusion Criteria:\n\n          -  complicated RUTI\n\n          -  other disease with urinary tract\n\n          -  infection by pathogens other than bacteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01745328", 
            "org_study_id": "WJUTI"
        }, 
        "intervention": [
            {
                "arm_group_label": "LVX-AMX", 
                "description": "Subjects were treated with Levofloxacin, 200mg bid, Amoxicillin, 500mg tid for 1 week, followed by 3 week of placebo.", 
                "intervention_name": "LVX-AMX", 
                "intervention_type": "Drug", 
                "other_name": "Levofloxacin, 200mg bid, Amoxicillin, 500mg tid"
            }, 
            {
                "arm_group_label": "TCM treatment", 
                "description": "Subject is treated with TCM  for 4 weeks.", 
                "intervention_name": "TCM", 
                "intervention_type": "Drug", 
                "other_name": "TCM formula consisted of 10 herbals"
            }, 
            {
                "arm_group_label": "LVX-AMX", 
                "description": "treatment with placebo from 2 to 4 weeks.", 
                "intervention_name": "LVX-AMX", 
                "intervention_type": "Drug", 
                "other_name": "placebo from 2 to 4 weeks."
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Amoxicillin", 
                "Ofloxacin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "recurrent urinary tract infection", 
            "antibiotics", 
            "traditional chinese medicine"
        ], 
        "lastchanged_date": "December 7, 2012", 
        "location": {
            "contact": {
                "email": "liushiwei1977@yeah.net", 
                "last_name": "Shiwei Liu, Dr", 
                "phone": "86-10-84739029"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100020"
                }, 
                "name": "Wangjing Hospital"
            }, 
            "investigator": {
                "last_name": "Shiwei Liu, Dr", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study on Treatment of Recurrent Urinary Tract Infection by Traditional Chinese Medicine", 
        "overall_contact": {
            "email": "liushiwei1977@yeah.net", 
            "last_name": "Shiwei Liu, Dr", 
            "phone": "86-10-84739029"
        }, 
        "overall_official": {
            "affiliation": "Insititute of Disease Control and Prevention", 
            "last_name": "Zeliang Chen, Dr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients are checked at 4 weeks at the end of the treatment to confirm recovery of RUTI.", 
            "measure": "Recovery of recurrent urinary tract infection", 
            "safety_issue": "No", 
            "time_frame": "4 weeks after study drug start"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01745328"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Urinary albumin is checked in patient urine.", 
                "measure": "Urinary albumin", 
                "safety_issue": "No", 
                "time_frame": "4 weeks  after drug start"
            }, 
            {
                "description": "Check the WBC count in patient urine.", 
                "measure": "WBC conversion", 
                "safety_issue": "No", 
                "time_frame": "4 weeks after drug start"
            }, 
            {
                "description": "Checked for urination frequency at 4 weeks after drug start.", 
                "measure": "Urination frequency", 
                "safety_issue": "No", 
                "time_frame": "4 weeks after drug start"
            }, 
            {
                "description": "Patients are checked for recurrence rate at 6 months after drug start by telephone interview.", 
                "measure": "Recurrence", 
                "safety_issue": "No", 
                "time_frame": "6 months after drug start"
            }, 
            {
                "description": "Check urgency 4 weeks after drug start", 
                "measure": "urgency", 
                "safety_issue": "No", 
                "time_frame": "4 weeks after drug start"
            }
        ], 
        "source": "Beijing Institute of Disease Control and Prevention", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing Institute of Disease Control and Prevention", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}